ExchangeDEX+

Buy Crypto Markets Spot Futures500X Earn Events

The post Injective Unveils No-Code Platform for Web3 Builders appeared on BitcoinEthereumNews.com. Injective, the blockchain project focused on decentralized finance (DeFi), has unveiled a no-code platform designed to let anyone build and deploy Web3 applications without writing a single line of code. New Platform Lets Users Create Web3 Apps Without Coding According to the announcement shared with Bitcoin.com News, the new platform dubbed iBuild operates on Injective’s […] Source: https://news.bitcoin.com/injective-unveils-no-code-platform-for-web3-builders/The post Injective Unveils No-Code Platform for Web3 Builders appeared on BitcoinEthereumNews.com. Injective, the blockchain project focused on decentralized finance (DeFi), has unveiled a no-code platform designed to let anyone build and deploy Web3 applications without writing a single line of code. New Platform Lets Users Create Web3 Apps Without Coding According to the announcement shared with Bitcoin.com News, the new platform dubbed iBuild operates on Injective’s […] Source: https://news.bitcoin.com/injective-unveils-no-code-platform-for-web3-builders/

Injective Unveils No-Code Platform for Web3 Builders

By: BitcoinEthereumNews

2025/11/05 23:49

FINANCE$0.0004971-1.85%

DEFI$0.000859+22.71%

ANYONE$0.5521+10.75%

LINE$0.0000115--%

Injective, the blockchain project focused on decentralized finance (DeFi), has unveiled a no-code platform designed to let anyone build and deploy Web3 applications without writing a single line of code. New Platform Lets Users Create Web3 Apps Without Coding According to the announcement shared with Bitcoin.com News, the new platform dubbed iBuild operates on Injective’s […]

Source: https://news.bitcoin.com/injective-unveils-no-code-platform-for-web3-builders/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

Share Insights